Analgesia Nociception Index to Explore Autonomic Nervous System in Patients With Continuous Renal Replacement Therapy
UFANI
Analgesia Nociception Index and Autonomic Nervous System Exploration During Continuous Renal Replacement Therapy in Intensive Care Patients.
2 other identifiers
observational
30
1 country
1
Brief Summary
The Analgesia Nociception Index (ANI) reflects the balance between sympathetic and parasympathetic tone. It is based on a specific interpretation of the R-R interval variation. During fluid removal by net ultrafiltration in patients with fluid overload and continuous renal replacement therapy, some data suggest that haemodynamic variation could be induced by the autonomic nervous system. The study aims to investigate ANI variations in this context and their association with the haemodynamic variations observed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Start
First participant enrolled
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
January 15, 2026
January 1, 2026
1.2 years
February 22, 2024
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of changes in ANI.
Relative changes in ANI (averaged over 4 minutes (percentage)) between Hour 0 and Hour 6 of initiation of net ultrafiltration.
6 hours after initiation of net ultrafiltration
Study Arms (1)
Critically ill patients with continuous renal replacement therapy.
The patients will be followed during the first 6 hours of the initiation of a net ultrafiltration (2-3 milliliters/kilograms/hour) with continuous monitoring (R-R interval, ANI, cardiac index, invasive arterial pressure, central venous pressure, peripheral perfusion index), and perfusion monitoring every 6 hours (arterial lactate, central venous oxygen saturation, capillary refill time, mottling score). Such a fluid removal strategy is part of an institutional protocol or an ongoing clinical trial. In addition to the usual monitoring, the PhysioDoloris monitor will be connected to the patient's scope. The ANI and its parameters will be recorded continuously throughout the study.
Eligibility Criteria
Critically ill patients with continuous renal replacement therapy, fluid overload and haemodynamically stable.
You may qualify if:
- Continuous renal replacement therapy in intensive care unit
- Initiation of net ultrafiltration according to the protocol of the department or to EARLYDRY study (NCT 05817539) (3 criteria required):
- Fluid overload \> 5% or peripheral oedema
- Noradrenaline equivalent \<0.5μg/kg/min
- No peripheral hypoperfusion
- Invasive blood pressure monitoring
- Central venous line in superior vena cava territory
- Regular sinus rhythm
- Patient awake or Richmond Agitation and Sedation Scale \> -3
You may not qualify if:
- Ongoing administration of inotropes
- Ongoing administration of beta blockers
- Current administration of alpha-2 agonists
- History of dysautonomia
- Pregnant or breast-feeding woman
- Mechanical circulatory assistance
- Opposition to participate
- Adults under legal protection
- Persons deprived of their liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Département d'anesthésie-réanimation Hôpital cardiologique Louis Pradel
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin RUSTE, MD
Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, HCL
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2024
First Posted
February 29, 2024
Study Start
January 9, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
January 15, 2026
Record last verified: 2026-01